|
1
|
Võsa U, Vooder T, Kolde R, et al:
Meta-analysis of microRNA expression in lung cancer. Int J Cancer.
132:2884–2893. 2013. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iorio MV, Ferracin M, Liu GC, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Porkka KP, Pfeiffer MJ, Waltering KK, et
al: MicroRNA expression profiling in prostate cancer. Cancer Res.
67:6130–6135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akao Y, Nakagawa Y and Naoe T:
MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 26:311–320.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Kong W, He L, et al: MicroRNA
expression profiling in human ovarian cancer: miR-214 induces cell
survival and cisplatin resistance by targeting PTEN. Cancer Res.
68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sablok G, Milev I, Minkov G, et al:
isomiRex: web-based identification of microRNAs, isomiR variations
and differential expression using next-generation sequencing
datasets. FEBS Lett. 587:2629–2634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trapnell C, Roberts A, Goff L, et al:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nature protocols. 7:562–578.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bindea G, Mlecnik B, Hackl H, et al:
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene
ontology and pathway annotation networks. Bioinformatics.
25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Re. 13:2498–2504. 2003.
View Article : Google Scholar
|
|
13
|
Bindea G, Galon J and Mlecnik B: CluePedia
Cytoscape plugin: Pathway insights using integrated experimental
and in silico data. Bioinformatics. 29:661–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozomara A and Griffiths-Jones S: miRBase:
integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39(Database issue): D152–D157. 2011. View Article : Google Scholar :
|
|
15
|
Xiao F, Zuo Z, Cai G, et al: miRecords: an
integrated resource for microRNA-target interactions. Nucleic Acids
Res. 37(Database issue): D105–D110. 2009. View Article : Google Scholar :
|
|
16
|
Albig AR, Neil JR and Schiemann WP:
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res.
66:2621–2629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yue W, Dacic S, Sun Q, et al: Frequent
inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter
hypermethylation. Clin Cancer Res. 13:4336–4344. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Raman V, Martensen SA, Reisman D, et al:
Compromised HOXA5 function can limit p53 expression in human breast
tumours. Nature. 405:974–978. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Lu K, Wang K, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schraml P, Shipman R, Colombi M and Ludwig
CU: Identification of genes differentially expressed in normal lung
and non-small cell lung carcinoma tissue. Cancer Res. 54:5236–5240.
1994.PubMed/NCBI
|
|
21
|
Yu S, Yu J, Ge W, et al: SPARCL1, Shp2,
MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in
colorectal cancer. World J Gastroenterol. 17:2028–2036. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anedchenko EA, Dmitriev AA, Krasnov GS, et
al: Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9,
HYAL1 and HYAL2 genes in non-small cell lung cancer. Mol Biol.
42:965–976. 2008.(in Russian). View Article : Google Scholar
|
|
23
|
Cheung W, Zhao M, Liu Z, et al: Control of
alveolar differentiation by the lineage transcription factors GATA6
and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell.
23:725–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou M, Du Y, Liu Y, et al: Clinical and
experimental studies regarding the expression and diagnostic value
of carcinoembryonic antigen-related cell adhesion molecule 1 in
non-small-cell-lung cancer. BMC Cancer. 13:3592013. View Article : Google Scholar
|
|
25
|
Kikuchi J, Kinoshita I, Shimizu Y, et al:
Minichromosome maintenance (MCM) protein 4 as a marker for
proliferation and its clinical and clinicopathological significance
in non-small cell lung cancer. Lung Cancer. 72:229–237. 2011.
View Article : Google Scholar
|
|
26
|
Guan P, Yin Z, Li X, et al: Meta-analysis
of human lung cancer microRNA expression profiling studies
comparing cancer tissues with normal tissues. J Exp Clin Cancer
Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grosso S, Doyen J, Parks SK, et al:
MiR-210 promotes a hypoxic phenotype and increases radioresistance
in human lung cancer cell lines. Cell Death Dis. 4:e5442013.
View Article : Google Scholar : PubMed/NCBI
|
